Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? [PDF]
Merola E +16 more
europepmc +1 more source
Somatostatin analogs in neuroendocrine tumors with Ki-67 index of ≥10. [PDF]
Braegelmann J +6 more
europepmc +1 more source
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. [PDF]
Fuentes-Fayos AC +9 more
europepmc +1 more source
Somatostatin Analogs Versus Active Surveillance in Small Pancreatic Neuroendocrine Tumors. [PDF]
Maratta MG +14 more
europepmc +1 more source
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs. [PDF]
Lenotti E +9 more
europepmc +1 more source
Somatostatin Analogs for Preventing Postoperative Pancreatic Fistula: Past Evidence Reveals New Opportunities. [PDF]
Goodsell KE +3 more
europepmc +1 more source
"Cold" Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy. [PDF]
Massironi S +6 more
europepmc +1 more source
Editorial: The role of radiotherapy in acromegaly [PDF]
Herder, W.W. (Wouter) de +2 more
core +2 more sources
Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin Analogs
P. Chanson
semanticscholar +1 more source
Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors. [PDF]
Santo G +3 more
europepmc +1 more source

